Oppenheimer lowered the firm’s price target on Ameresco to $64 from $76 on valuation, while keeping an Outperform rating on the shares. The firm notes shares traded down after hours Monday following Amerescos’ below-consensus Q4 miss and Q1 2023 guidance, reflecting timing delays for both Projects and Assets segments. However, full year 2023 EBITDA guidance, though back-weighted, was in line with the Street and reflects line of sight to key projects’ mid-year completion, Oppenheimer adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AMRC: